Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-05-24

AUTHORS

Jennifer M. Knight, Stephanie A. Kerswill, Parameswaran Hari, Steve W. Cole, Brent R. Logan, Anita D’Souza, Nirav N. Shah, Mary M. Horowitz, Melinda R. Stolley, Erica K. Sloan, Karen E. Giles, Erin S. Costanzo, Mehdi Hamadani, Saurabh Chhabra, Binod Dhakal, J. Douglas Rizzo

ABSTRACT

BackgroundRepurposing existing medications for antineoplastic purposes can provide a safe, cost-effective, and efficacious means to further augment available cancer care. Clinical and preclinical studies suggest a role for the ß-adrenergic antagonist (ß-blocker) propranolol in reducing rates of tumor progression in both solid and hematologic malignancies. In patients undergoing hematopoietic cell transplantation (HCT), the peri-transplant period is a time of increased activity of the ß-adrenergically-mediated stress response.MethodsWe conducted a proof-of-concept randomized controlled pilot study assessing the feasibility of propranolol administration to patients between ages 18–75 who received an autologous HCT for multiple myeloma. Feasibility was assessed by enrollment rate, tolerability, adherence, and retention.ResultsOne hundred fifty-four patients underwent screening; 31 (20%) enrolled in other oncology trials that precluded dual trial enrollment and 9 (6%) declined to enroll in the current trial. Eighty-nine (58%) did not meet eligibility requirements and 25 (16%) were eligible; of the remaining eligible patients, all were successfully enrolled and randomized. The most common reasons for ineligibility were current ß-blocker use, age, logistics, and medical contraindications. 92% of treatment arm patients tolerated and remained on propranolol for the study duration; 1 patient discontinued due to hypotension. Adherence rate in assessable patients (n = 10) was 94%. Study retention was 100%.ConclusionsFindings show that it is feasible to recruit and treat multiple myeloma patients with propranolol during HCT, with the greatest obstacle being other competing oncology trials. These data support further studies examining propranolol and other potentially repurposed drugs in oncology populations.Trial registrationThis randomized controlled trial was registered at clinicaltrials.gov with the identifier NCT02420223 on April 17, 2015. More... »

PAGES

593

References to SciGraph publications

  • 2004-10-25. Routine screening for psychosocial distress following hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2006-03. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms in NATURE REVIEWS CANCER
  • 2012-10-19. New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2007-09-13. Social regulation of gene expression in human leukocytes in GENOME BIOLOGY
  • 2006-06-19. Do negative or positive emotions differentially impact mortality after adult stem cell transplant? in BONE MARROW TRANSPLANTATION
  • 2011-05-23. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30 in BONE MARROW TRANSPLANTATION
  • 1998-03-01. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year in BONE MARROW TRANSPLANTATION
  • 2015-08-24. Sympathetic nervous system regulation of the tumour microenvironment in NATURE REVIEWS CANCER
  • 2011-08-05. Reciprocal regulation of the neural and innate immune systems in NATURE REVIEWS IMMUNOLOGY
  • 2008-03-26. Health-related quality of life among adults with serious psychological distress and chronic medical conditions in QUALITY OF LIFE RESEARCH
  • 2015-10-20. Drug repurposing in oncology—patient and health systems opportunities in NATURE REVIEWS CLINICAL ONCOLOGY
  • Journal

    TITLE

    BMC Cancer

    ISSUE

    1

    VOLUME

    18

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12885-018-4509-0

    DOI

    http://dx.doi.org/10.1186/s12885-018-4509-0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1104168496

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29793446


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adrenergic beta-Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chemotherapy, Adjuvant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Progression", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Repositioning", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Feasibility Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Multiple Myeloma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Patient Compliance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pilot Projects", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proof of Concept Study", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Propranolol", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Research Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transplantation, Autologous", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Young Adult", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Departments of Psychiatry, Medicine, and Microbiology & Immunology, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Knight", 
            "givenName": "Jennifer M.", 
            "id": "sg:person.01106161351.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106161351.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Wisconsin, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Medical College of Wisconsin, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kerswill", 
            "givenName": "Stephanie A.", 
            "id": "sg:person.016017161004.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016017161004.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hari", 
            "givenName": "Parameswaran", 
            "id": "sg:person.01170403141.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Division of Hematology-Oncology, and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.19006.3e", 
              "name": [
                "Department of Medicine, Division of Hematology-Oncology, and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cole", 
            "givenName": "Steve W.", 
            "id": "sg:person.07554162312.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07554162312.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Biostatistics, Institute for Health & Society, Medical College of Wisconsin, Milwaukee, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA", 
                "Division of Biostatistics, Institute for Health & Society, Medical College of Wisconsin, Milwaukee, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Logan", 
            "givenName": "Brent R.", 
            "id": "sg:person.0604532000.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604532000.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
                "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "D\u2019Souza", 
            "givenName": "Anita", 
            "id": "sg:person.01152771506.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152771506.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shah", 
            "givenName": "Nirav N.", 
            "id": "sg:person.015270014615.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015270014615.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
                "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Horowitz", 
            "givenName": "Mary M.", 
            "id": "sg:person.010360225632.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010360225632.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stolley", 
            "givenName": "Melinda R.", 
            "id": "sg:person.016566202147.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016566202147.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, VIC, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1055.1", 
              "name": [
                "Monash Institute of Pharmaceutical Sciences, Monash University, Clayton, VIC, Australia", 
                "Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, and UCLA AIDS Institute, UCLA, Los Angeles, CA, USA", 
                "Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, VIC, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sloan", 
            "givenName": "Erica K.", 
            "id": "sg:person.01226143323.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226143323.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Wisconsin, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Medical College of Wisconsin, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Giles", 
            "givenName": "Karen E.", 
            "id": "sg:person.014717632706.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014717632706.02"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Carbone Cancer Center and Department of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.14003.36", 
              "name": [
                "Carbone Cancer Center and Department of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Costanzo", 
            "givenName": "Erin S.", 
            "id": "sg:person.0717476233.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717476233.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
                "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hamadani", 
            "givenName": "Mehdi", 
            "id": "sg:person.01333152475.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333152475.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chhabra", 
            "givenName": "Saurabh", 
            "id": "sg:person.012647475207.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012647475207.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dhakal", 
            "givenName": "Binod", 
            "id": "sg:person.01047372670.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047372670.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA", 
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "name": [
                "Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA", 
                "Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rizzo", 
            "givenName": "J. Douglas", 
            "id": "sg:person.0735274405.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735274405.45"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrc1820", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014613805", 
              "https://doi.org/10.1038/nrc1820"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11136-008-9330-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013059643", 
              "https://doi.org/10.1007/s11136-008-9330-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1701115", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001832546", 
              "https://doi.org/10.1038/sj.bmt.1701115"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2015.169", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047157332", 
              "https://doi.org/10.1038/nrclinonc.2015.169"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00432-012-1331-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025806074", 
              "https://doi.org/10.1007/s00432-012-1331-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bmt.2011.107", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014012805", 
              "https://doi.org/10.1038/bmt.2011.107"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1704709", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014866337", 
              "https://doi.org/10.1038/sj.bmt.1704709"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc3978", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029154545", 
              "https://doi.org/10.1038/nrc3978"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/gb-2007-8-9-r189", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039129712", 
              "https://doi.org/10.1186/gb-2007-8-9-r189"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1705419", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013542743", 
              "https://doi.org/10.1038/sj.bmt.1705419"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nri3042", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032780647", 
              "https://doi.org/10.1038/nri3042"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-05-24", 
        "datePublishedReg": "2018-05-24", 
        "description": "BackgroundRepurposing existing medications for antineoplastic purposes can provide a safe, cost-effective, and efficacious means to further augment available cancer care. Clinical and preclinical studies suggest a role for the \u00df-adrenergic antagonist (\u00df-blocker) propranolol in reducing rates of tumor progression in both solid and hematologic malignancies. In patients undergoing hematopoietic cell transplantation (HCT), the peri-transplant period is a time of increased activity of the \u00df-adrenergically-mediated stress response.MethodsWe conducted a proof-of-concept randomized controlled pilot study assessing the feasibility of propranolol administration to patients between ages 18\u201375 who received an autologous HCT for multiple myeloma. Feasibility was assessed by enrollment rate, tolerability, adherence, and retention.ResultsOne hundred fifty-four patients underwent screening; 31 (20%) enrolled in other oncology trials that precluded dual trial enrollment and 9 (6%) declined to enroll in the current trial. Eighty-nine (58%) did not meet eligibility requirements and 25 (16%) were eligible; of the remaining eligible patients, all were successfully enrolled and randomized. The most common reasons for ineligibility were current \u00df-blocker use, age, logistics, and medical contraindications. 92% of treatment arm patients tolerated and remained on propranolol for the study duration; 1 patient discontinued due to hypotension. Adherence rate in assessable patients (n\u00a0=\u200910) was 94%. Study retention was 100%.ConclusionsFindings show that it is feasible to recruit and treat multiple myeloma patients with propranolol during HCT, with the greatest obstacle being other competing oncology trials. These data support further studies examining propranolol and other potentially repurposed drugs in oncology populations.Trial registrationThis randomized controlled trial was registered at clinicaltrials.gov with the identifier NCT02420223 on April 17, 2015.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12885-018-4509-0", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2343593", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.4242340", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.4243900", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1024632", 
            "issn": [
              "1471-2407"
            ], 
            "name": "BMC Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "18"
          }
        ], 
        "keywords": [
          "hematopoietic cell transplantation", 
          "propranolol administration", 
          "cell transplantation", 
          "oncology trials", 
          "autologous hematopoietic cell transplantation", 
          "peri-transplant period", 
          "\u00df-blocker use", 
          "multiple myeloma patients", 
          "ResultsOne hundred fifty", 
          "adrenergic antagonist propranolol", 
          "treatment arm patients", 
          "eligible patients", 
          "assessable patients", 
          "medical contraindications", 
          "ARM patients", 
          "oncology population", 
          "trial enrollment", 
          "myeloma patients", 
          "multiple myeloma", 
          "adherence rates", 
          "cancer care", 
          "antagonist propranolol", 
          "hematologic malignancies", 
          "hundred fifty", 
          "preclinical studies", 
          "study retention", 
          "common reason", 
          "patients", 
          "study duration", 
          "randomized pilot", 
          "tumor progression", 
          "current trial", 
          "propranolol", 
          "age 18", 
          "pilot study", 
          "trials", 
          "cancer therapy", 
          "efficacious means", 
          "medications", 
          "Further studies", 
          "transplantation", 
          "eligibility requirements", 
          "administration", 
          "hypotension", 
          "tolerability", 
          "contraindications", 
          "myeloma", 
          "malignancy", 
          "therapy", 
          "MethodsWe", 
          "stress response", 
          "ineligibility", 
          "progression", 
          "care", 
          "study", 
          "adherence", 
          "drugs", 
          "enrollment rates", 
          "age", 
          "rate", 
          "enrollment", 
          "duration", 
          "ConclusionsFindings", 
          "screening", 
          "population", 
          "fifties", 
          "response", 
          "feasibility", 
          "retention", 
          "period", 
          "activity", 
          "role", 
          "greatest obstacle", 
          "pilot", 
          "use", 
          "purpose", 
          "data", 
          "reasons", 
          "time", 
          "means", 
          "identifiers", 
          "obstacles", 
          "design", 
          "requirements", 
          "proof", 
          "logistics", 
          "concept"
        ], 
        "name": "Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation", 
        "pagination": "593", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1104168496"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12885-018-4509-0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29793446"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12885-018-4509-0", 
          "https://app.dimensions.ai/details/publication/pub.1104168496"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:44", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_776.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12885-018-4509-0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4509-0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4509-0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4509-0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4509-0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    406 TRIPLES      21 PREDICATES      144 URIs      125 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12885-018-4509-0 schema:about N1759f72dfe4944cdb84a09312f49c985
    2 N1853e99de4d345edaca33295f11f481f
    3 N1c28c5ef7963430789ffa74eae675897
    4 N27290390eb6344b9b9d9c564b9788798
    5 N2aebe74fc5f049ae945ba270cdf936fe
    6 N43076996c58e400dad98816281e6c2b3
    7 N4d82d56422714d33908d94f7d4747b97
    8 N54cb03ee3dc4458db64c479612072598
    9 N68e78ee079b64ed9b50479f326f3c25a
    10 N6c537f1dd21540dbb60d4154a9cdb3f9
    11 N7230f0daa1e64fcf81cc8f2b1cd8aa18
    12 N8285b2f60f694b3c8c4f69e6398b8538
    13 N8846f37f344e48acb1a0ff3d1b6f46d0
    14 N888b5877036047fea2c67ef4e78ffe20
    15 Na8eb808631e9400cb005a2eef82542d7
    16 Na902ad82a5364006bfd10e662326d34e
    17 Nadd78315cede43eb827e9840e6e2bf79
    18 Nae10b236f17d48c69626311684199545
    19 Nd1026523c7b0446f86ed355b00d5b4cd
    20 Ndf45398eaa9a408fb456367065e22e9d
    21 Nec2a0e5246b148c19946e57aa3c9e09d
    22 anzsrc-for:11
    23 anzsrc-for:1112
    24 schema:author Naaaccb1c9dc94221896f194ca5d87fde
    25 schema:citation sg:pub.10.1007/s00432-012-1331-y
    26 sg:pub.10.1007/s11136-008-9330-9
    27 sg:pub.10.1038/bmt.2011.107
    28 sg:pub.10.1038/nrc1820
    29 sg:pub.10.1038/nrc3978
    30 sg:pub.10.1038/nrclinonc.2015.169
    31 sg:pub.10.1038/nri3042
    32 sg:pub.10.1038/sj.bmt.1701115
    33 sg:pub.10.1038/sj.bmt.1704709
    34 sg:pub.10.1038/sj.bmt.1705419
    35 sg:pub.10.1186/gb-2007-8-9-r189
    36 schema:datePublished 2018-05-24
    37 schema:datePublishedReg 2018-05-24
    38 schema:description BackgroundRepurposing existing medications for antineoplastic purposes can provide a safe, cost-effective, and efficacious means to further augment available cancer care. Clinical and preclinical studies suggest a role for the ß-adrenergic antagonist (ß-blocker) propranolol in reducing rates of tumor progression in both solid and hematologic malignancies. In patients undergoing hematopoietic cell transplantation (HCT), the peri-transplant period is a time of increased activity of the ß-adrenergically-mediated stress response.MethodsWe conducted a proof-of-concept randomized controlled pilot study assessing the feasibility of propranolol administration to patients between ages 18–75 who received an autologous HCT for multiple myeloma. Feasibility was assessed by enrollment rate, tolerability, adherence, and retention.ResultsOne hundred fifty-four patients underwent screening; 31 (20%) enrolled in other oncology trials that precluded dual trial enrollment and 9 (6%) declined to enroll in the current trial. Eighty-nine (58%) did not meet eligibility requirements and 25 (16%) were eligible; of the remaining eligible patients, all were successfully enrolled and randomized. The most common reasons for ineligibility were current ß-blocker use, age, logistics, and medical contraindications. 92% of treatment arm patients tolerated and remained on propranolol for the study duration; 1 patient discontinued due to hypotension. Adherence rate in assessable patients (n = 10) was 94%. Study retention was 100%.ConclusionsFindings show that it is feasible to recruit and treat multiple myeloma patients with propranolol during HCT, with the greatest obstacle being other competing oncology trials. These data support further studies examining propranolol and other potentially repurposed drugs in oncology populations.Trial registrationThis randomized controlled trial was registered at clinicaltrials.gov with the identifier NCT02420223 on April 17, 2015.
    39 schema:genre article
    40 schema:isAccessibleForFree true
    41 schema:isPartOf N2b1ed48fc7c04afd8c1590bed0a96f39
    42 N6a34e98e80594cd5a46736ba5d91e933
    43 sg:journal.1024632
    44 schema:keywords ARM patients
    45 ConclusionsFindings
    46 Further studies
    47 MethodsWe
    48 ResultsOne hundred fifty
    49 activity
    50 adherence
    51 adherence rates
    52 administration
    53 adrenergic antagonist propranolol
    54 age
    55 age 18
    56 antagonist propranolol
    57 assessable patients
    58 autologous hematopoietic cell transplantation
    59 cancer care
    60 cancer therapy
    61 care
    62 cell transplantation
    63 common reason
    64 concept
    65 contraindications
    66 current trial
    67 data
    68 design
    69 drugs
    70 duration
    71 efficacious means
    72 eligibility requirements
    73 eligible patients
    74 enrollment
    75 enrollment rates
    76 feasibility
    77 fifties
    78 greatest obstacle
    79 hematologic malignancies
    80 hematopoietic cell transplantation
    81 hundred fifty
    82 hypotension
    83 identifiers
    84 ineligibility
    85 logistics
    86 malignancy
    87 means
    88 medical contraindications
    89 medications
    90 multiple myeloma
    91 multiple myeloma patients
    92 myeloma
    93 myeloma patients
    94 obstacles
    95 oncology population
    96 oncology trials
    97 patients
    98 peri-transplant period
    99 period
    100 pilot
    101 pilot study
    102 population
    103 preclinical studies
    104 progression
    105 proof
    106 propranolol
    107 propranolol administration
    108 purpose
    109 randomized pilot
    110 rate
    111 reasons
    112 requirements
    113 response
    114 retention
    115 role
    116 screening
    117 stress response
    118 study
    119 study duration
    120 study retention
    121 therapy
    122 time
    123 tolerability
    124 transplantation
    125 treatment arm patients
    126 trial enrollment
    127 trials
    128 tumor progression
    129 use
    130 ß-blocker use
    131 schema:name Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation
    132 schema:pagination 593
    133 schema:productId N6fe9b5ca8b4e4b7982626e062ab4c630
    134 N8774869e8ba940e3bec6dc868d617368
    135 N91606dc7dc9f44c0802edc639073ac67
    136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104168496
    137 https://doi.org/10.1186/s12885-018-4509-0
    138 schema:sdDatePublished 2022-10-01T06:44
    139 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    140 schema:sdPublisher Ne752c3fe120c47399b163c12d0cf5b70
    141 schema:url https://doi.org/10.1186/s12885-018-4509-0
    142 sgo:license sg:explorer/license/
    143 sgo:sdDataset articles
    144 rdf:type schema:ScholarlyArticle
    145 N1759f72dfe4944cdb84a09312f49c985 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Middle Aged
    147 rdf:type schema:DefinedTerm
    148 N1853e99de4d345edaca33295f11f481f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Research Design
    150 rdf:type schema:DefinedTerm
    151 N1c28c5ef7963430789ffa74eae675897 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Pilot Projects
    153 rdf:type schema:DefinedTerm
    154 N1dc70dfba8154853ad5a270cd41e1dac rdf:first sg:person.014717632706.02
    155 rdf:rest N8ad887a11c684019932e4ef888e82ff0
    156 N27290390eb6344b9b9d9c564b9788798 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Drug Repositioning
    158 rdf:type schema:DefinedTerm
    159 N2aebe74fc5f049ae945ba270cdf936fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Hematopoietic Stem Cell Transplantation
    161 rdf:type schema:DefinedTerm
    162 N2b1ed48fc7c04afd8c1590bed0a96f39 schema:volumeNumber 18
    163 rdf:type schema:PublicationVolume
    164 N2fa0d0c1a17547bfb7082a12968aff9c rdf:first sg:person.010360225632.91
    165 rdf:rest Nc461e13b6c9d4f6d93fe706916b1d0fb
    166 N35d93061b8744096b77683f9047ddf53 rdf:first sg:person.016017161004.68
    167 rdf:rest Na3525e4655024dbfa0d02f5542e2ac63
    168 N43076996c58e400dad98816281e6c2b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Adrenergic beta-Antagonists
    170 rdf:type schema:DefinedTerm
    171 N4d82d56422714d33908d94f7d4747b97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Transplantation, Autologous
    173 rdf:type schema:DefinedTerm
    174 N54cb03ee3dc4458db64c479612072598 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Multiple Myeloma
    176 rdf:type schema:DefinedTerm
    177 N68e78ee079b64ed9b50479f326f3c25a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Male
    179 rdf:type schema:DefinedTerm
    180 N6a34e98e80594cd5a46736ba5d91e933 schema:issueNumber 1
    181 rdf:type schema:PublicationIssue
    182 N6c537f1dd21540dbb60d4154a9cdb3f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Feasibility Studies
    184 rdf:type schema:DefinedTerm
    185 N6fe9b5ca8b4e4b7982626e062ab4c630 schema:name pubmed_id
    186 schema:value 29793446
    187 rdf:type schema:PropertyValue
    188 N7230f0daa1e64fcf81cc8f2b1cd8aa18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Treatment Outcome
    190 rdf:type schema:DefinedTerm
    191 N7a6d606d4458494486b60d3f6b3fa624 rdf:first sg:person.0604532000.22
    192 rdf:rest Nc400020b4c5e4636941dbf252f8e2bbf
    193 N7f9e3ec31d634a9cad06fdd708ef938e rdf:first sg:person.01047372670.01
    194 rdf:rest Nd75ce48d9b8d4998b3f84b8e6a439d5d
    195 N8285b2f60f694b3c8c4f69e6398b8538 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Aged
    197 rdf:type schema:DefinedTerm
    198 N8774869e8ba940e3bec6dc868d617368 schema:name dimensions_id
    199 schema:value pub.1104168496
    200 rdf:type schema:PropertyValue
    201 N8846f37f344e48acb1a0ff3d1b6f46d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Propranolol
    203 rdf:type schema:DefinedTerm
    204 N888b5877036047fea2c67ef4e78ffe20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Female
    206 rdf:type schema:DefinedTerm
    207 N8ad887a11c684019932e4ef888e82ff0 rdf:first sg:person.0717476233.78
    208 rdf:rest Nd6deb6605994477b9b5244701ea95a62
    209 N91606dc7dc9f44c0802edc639073ac67 schema:name doi
    210 schema:value 10.1186/s12885-018-4509-0
    211 rdf:type schema:PropertyValue
    212 Na2e2aa3b651b43b8b54162836a27e566 rdf:first sg:person.07554162312.13
    213 rdf:rest N7a6d606d4458494486b60d3f6b3fa624
    214 Na3525e4655024dbfa0d02f5542e2ac63 rdf:first sg:person.01170403141.13
    215 rdf:rest Na2e2aa3b651b43b8b54162836a27e566
    216 Na8eb808631e9400cb005a2eef82542d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    217 schema:name Adult
    218 rdf:type schema:DefinedTerm
    219 Na902ad82a5364006bfd10e662326d34e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    220 schema:name Chemotherapy, Adjuvant
    221 rdf:type schema:DefinedTerm
    222 Naaaccb1c9dc94221896f194ca5d87fde rdf:first sg:person.01106161351.14
    223 rdf:rest N35d93061b8744096b77683f9047ddf53
    224 Nadd78315cede43eb827e9840e6e2bf79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Proof of Concept Study
    226 rdf:type schema:DefinedTerm
    227 Nae10b236f17d48c69626311684199545 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Disease Progression
    229 rdf:type schema:DefinedTerm
    230 Nc400020b4c5e4636941dbf252f8e2bbf rdf:first sg:person.01152771506.25
    231 rdf:rest Ndf1ead6393484c11a9be0353a377e5f8
    232 Nc461e13b6c9d4f6d93fe706916b1d0fb rdf:first sg:person.016566202147.04
    233 rdf:rest Nc6615a956c23463e9c68c8710f868af3
    234 Nc6615a956c23463e9c68c8710f868af3 rdf:first sg:person.01226143323.92
    235 rdf:rest N1dc70dfba8154853ad5a270cd41e1dac
    236 Nd1026523c7b0446f86ed355b00d5b4cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    237 schema:name Young Adult
    238 rdf:type schema:DefinedTerm
    239 Nd2cc2e4d34e744a781d709f3e91b0554 rdf:first sg:person.012647475207.14
    240 rdf:rest N7f9e3ec31d634a9cad06fdd708ef938e
    241 Nd6deb6605994477b9b5244701ea95a62 rdf:first sg:person.01333152475.54
    242 rdf:rest Nd2cc2e4d34e744a781d709f3e91b0554
    243 Nd75ce48d9b8d4998b3f84b8e6a439d5d rdf:first sg:person.0735274405.45
    244 rdf:rest rdf:nil
    245 Ndf1ead6393484c11a9be0353a377e5f8 rdf:first sg:person.015270014615.39
    246 rdf:rest N2fa0d0c1a17547bfb7082a12968aff9c
    247 Ndf45398eaa9a408fb456367065e22e9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    248 schema:name Patient Compliance
    249 rdf:type schema:DefinedTerm
    250 Ne752c3fe120c47399b163c12d0cf5b70 schema:name Springer Nature - SN SciGraph project
    251 rdf:type schema:Organization
    252 Nec2a0e5246b148c19946e57aa3c9e09d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    253 schema:name Humans
    254 rdf:type schema:DefinedTerm
    255 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    256 schema:name Medical and Health Sciences
    257 rdf:type schema:DefinedTerm
    258 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    259 schema:name Oncology and Carcinogenesis
    260 rdf:type schema:DefinedTerm
    261 sg:grant.2343593 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-018-4509-0
    262 rdf:type schema:MonetaryGrant
    263 sg:grant.4242340 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-018-4509-0
    264 rdf:type schema:MonetaryGrant
    265 sg:grant.4243900 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-018-4509-0
    266 rdf:type schema:MonetaryGrant
    267 sg:journal.1024632 schema:issn 1471-2407
    268 schema:name BMC Cancer
    269 schema:publisher Springer Nature
    270 rdf:type schema:Periodical
    271 sg:person.010360225632.91 schema:affiliation grid-institutes:grid.30760.32
    272 schema:familyName Horowitz
    273 schema:givenName Mary M.
    274 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010360225632.91
    275 rdf:type schema:Person
    276 sg:person.01047372670.01 schema:affiliation grid-institutes:grid.30760.32
    277 schema:familyName Dhakal
    278 schema:givenName Binod
    279 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047372670.01
    280 rdf:type schema:Person
    281 sg:person.01106161351.14 schema:affiliation grid-institutes:grid.30760.32
    282 schema:familyName Knight
    283 schema:givenName Jennifer M.
    284 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106161351.14
    285 rdf:type schema:Person
    286 sg:person.01152771506.25 schema:affiliation grid-institutes:grid.30760.32
    287 schema:familyName D’Souza
    288 schema:givenName Anita
    289 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152771506.25
    290 rdf:type schema:Person
    291 sg:person.01170403141.13 schema:affiliation grid-institutes:grid.30760.32
    292 schema:familyName Hari
    293 schema:givenName Parameswaran
    294 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13
    295 rdf:type schema:Person
    296 sg:person.01226143323.92 schema:affiliation grid-institutes:grid.1055.1
    297 schema:familyName Sloan
    298 schema:givenName Erica K.
    299 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226143323.92
    300 rdf:type schema:Person
    301 sg:person.012647475207.14 schema:affiliation grid-institutes:grid.30760.32
    302 schema:familyName Chhabra
    303 schema:givenName Saurabh
    304 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012647475207.14
    305 rdf:type schema:Person
    306 sg:person.01333152475.54 schema:affiliation grid-institutes:grid.30760.32
    307 schema:familyName Hamadani
    308 schema:givenName Mehdi
    309 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333152475.54
    310 rdf:type schema:Person
    311 sg:person.014717632706.02 schema:affiliation grid-institutes:grid.30760.32
    312 schema:familyName Giles
    313 schema:givenName Karen E.
    314 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014717632706.02
    315 rdf:type schema:Person
    316 sg:person.015270014615.39 schema:affiliation grid-institutes:grid.30760.32
    317 schema:familyName Shah
    318 schema:givenName Nirav N.
    319 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015270014615.39
    320 rdf:type schema:Person
    321 sg:person.016017161004.68 schema:affiliation grid-institutes:grid.30760.32
    322 schema:familyName Kerswill
    323 schema:givenName Stephanie A.
    324 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016017161004.68
    325 rdf:type schema:Person
    326 sg:person.016566202147.04 schema:affiliation grid-institutes:grid.30760.32
    327 schema:familyName Stolley
    328 schema:givenName Melinda R.
    329 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016566202147.04
    330 rdf:type schema:Person
    331 sg:person.0604532000.22 schema:affiliation grid-institutes:grid.30760.32
    332 schema:familyName Logan
    333 schema:givenName Brent R.
    334 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604532000.22
    335 rdf:type schema:Person
    336 sg:person.0717476233.78 schema:affiliation grid-institutes:grid.14003.36
    337 schema:familyName Costanzo
    338 schema:givenName Erin S.
    339 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717476233.78
    340 rdf:type schema:Person
    341 sg:person.0735274405.45 schema:affiliation grid-institutes:grid.30760.32
    342 schema:familyName Rizzo
    343 schema:givenName J. Douglas
    344 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735274405.45
    345 rdf:type schema:Person
    346 sg:person.07554162312.13 schema:affiliation grid-institutes:grid.19006.3e
    347 schema:familyName Cole
    348 schema:givenName Steve W.
    349 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07554162312.13
    350 rdf:type schema:Person
    351 sg:pub.10.1007/s00432-012-1331-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1025806074
    352 https://doi.org/10.1007/s00432-012-1331-y
    353 rdf:type schema:CreativeWork
    354 sg:pub.10.1007/s11136-008-9330-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013059643
    355 https://doi.org/10.1007/s11136-008-9330-9
    356 rdf:type schema:CreativeWork
    357 sg:pub.10.1038/bmt.2011.107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014012805
    358 https://doi.org/10.1038/bmt.2011.107
    359 rdf:type schema:CreativeWork
    360 sg:pub.10.1038/nrc1820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014613805
    361 https://doi.org/10.1038/nrc1820
    362 rdf:type schema:CreativeWork
    363 sg:pub.10.1038/nrc3978 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029154545
    364 https://doi.org/10.1038/nrc3978
    365 rdf:type schema:CreativeWork
    366 sg:pub.10.1038/nrclinonc.2015.169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047157332
    367 https://doi.org/10.1038/nrclinonc.2015.169
    368 rdf:type schema:CreativeWork
    369 sg:pub.10.1038/nri3042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032780647
    370 https://doi.org/10.1038/nri3042
    371 rdf:type schema:CreativeWork
    372 sg:pub.10.1038/sj.bmt.1701115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001832546
    373 https://doi.org/10.1038/sj.bmt.1701115
    374 rdf:type schema:CreativeWork
    375 sg:pub.10.1038/sj.bmt.1704709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014866337
    376 https://doi.org/10.1038/sj.bmt.1704709
    377 rdf:type schema:CreativeWork
    378 sg:pub.10.1038/sj.bmt.1705419 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013542743
    379 https://doi.org/10.1038/sj.bmt.1705419
    380 rdf:type schema:CreativeWork
    381 sg:pub.10.1186/gb-2007-8-9-r189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039129712
    382 https://doi.org/10.1186/gb-2007-8-9-r189
    383 rdf:type schema:CreativeWork
    384 grid-institutes:grid.1055.1 schema:alternateName Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, VIC, Australia
    385 schema:name Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, and UCLA AIDS Institute, UCLA, Los Angeles, CA, USA
    386 Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, VIC, Australia
    387 Monash Institute of Pharmaceutical Sciences, Monash University, Clayton, VIC, Australia
    388 rdf:type schema:Organization
    389 grid-institutes:grid.14003.36 schema:alternateName Carbone Cancer Center and Department of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA
    390 schema:name Carbone Cancer Center and Department of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA
    391 rdf:type schema:Organization
    392 grid-institutes:grid.19006.3e schema:alternateName Department of Medicine, Division of Hematology-Oncology, and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    393 schema:name Department of Medicine, Division of Hematology-Oncology, and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    394 rdf:type schema:Organization
    395 grid-institutes:grid.30760.32 schema:alternateName Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA
    396 Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
    397 Division of Biostatistics, Institute for Health & Society, Medical College of Wisconsin, Milwaukee, USA
    398 Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA
    399 Medical College of Wisconsin, Milwaukee, WI, USA
    400 schema:name Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin, Milwaukee, WI, USA
    401 Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
    402 Departments of Psychiatry, Medicine, and Microbiology & Immunology, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA
    403 Division of Biostatistics, Institute for Health & Society, Medical College of Wisconsin, Milwaukee, USA
    404 Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA
    405 Medical College of Wisconsin, Milwaukee, WI, USA
    406 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...